Istituto Neurologico Mediterraneo Neuromed S. R. L
7
2
3
0
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 7 trials
0%
0 trials in Phase 3/4
0%
0 of 0 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Physical Activity-based Intervention in Depressed Patients: Clinical, Neurophysiological, Epigenetic and Metabolic Correlates
Role: collaborator
Novel Risk Prediction Approaches for the Primary Prevention of Cardiovascular Diseases in Italy: the CVRISK-IT Trial (CVRISK-IT)
Role: collaborator
Next Generation Sequencing Analysis of Patients with Spontaneous Dissection of Cervical Arteries
Role: collaborator
Clinical, Molecular and Electrophysiological Profiling of Parkinson's Disease: the Role of Non-pharmacological Therapies
Role: collaborator
National Database of the Virtual Institute of Cerebrovascular Diseases
Role: collaborator
Immunisation Status and Safety of Vaccines in Italian MS Patients
Role: collaborator
Hypercoagulation Screening in Cancer
Role: collaborator
All 7 trials loaded